Skip to main content

Doctors discuss bioweapons

Possible threats and protection of sensitive research explored at medical meeting.

Written byEugene Russo
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00

WASHINGTON, D.C.—At its recent meeting, held October 2-5, the World Medical Association for the first time focused its scientific sessions on the growing threat of bioterrorism and biological weapons. The talks were intended to advise physicians attending from 27 nations on the state of the threat and to help national medical associations form their own policies regarding bioterrorism.

At a session titled, "Working Together Internationally for Bioweapons Prevention," speakers discussed the need to better define and control hazardous pathogens, and suggested ways to do so. John Steinbruner, a professor of public policy at the University of Maryland, reminded the audience that the same science that leads to better therapies can be used to craft pathogenic bioweapons—and that more rigorous regulations on such research are needed.

Echoing similar suggestions recently made to the Centers of Disease Control and Prevention (CDC) by the research community, Steinbruner proposed a conceptual scheme for distinguishing ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

Related articles background image
August 2026 Digest cover
August 2026

Epic Fail: Sea-Monkeys Sabotage Fieldwork

When Barry Hicks set out to photograph thrombolites, thousands of unexpected visitors photobombed his underwater images.

View this Issue
Improving rAAV Production for Viral Vector Manufacturing

Improving rAAV Production for Viral Vector Manufacturing

cytiva logo
Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Advancing Respiratory Immunity Through Tissue-Resident Memory T Cell Research

Miltenyi
Scientist holding a clear 384-well PCR microplate in a laboratory

What Dictates PCR Success Before Amplification Begins?

Integra Logo
Overcoming Immunotherapy Resistance in Liver Cancer

Overcoming Immunotherapy Resistance in Liver Cancer

Axion Biosystems

Products

Sino Biological Logo

Sino Biological Launches European Newsletter Campaign with Exclusive Welcome Gifts

Sino Biological Logo

Sino Biological Launches SuperNuclease ® Pro with Free Trial Program

Sino Biological Logo

Sino Biological Launches Precisely Characterized Full-Length p-Tau217 Protein to Advance Next-Generation Alzheimer’s Biomarker Assay Development

A photo of a scientist placing the Resipher device on a 96-well plate.

Resipher: Continuous Live-Cell Mitochondrial Respiration Monitoring in 96-Well Plates

Lucid Scientific logo